Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2018

Feb 5, 2018

35081_dirs_2018-02-05_c11ecc2f-c4b7-40ae-ad30-f6d5f1b16825.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2017-10-03

Reporting Person: Allen Richard T (Vice President of Quality)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-10-03 Common Stock M 574749 $0.15 Acquired 574749 Direct
2017-10-03 Common Stock M 232842 $0.15 Acquired 807591 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-10-03 Employee Stock Option (Right to Buy) $0.15 M 574749 Disposed 2026-08-09 Common Stock (574749) Direct
2017-10-03 Employee Stock Option (Right to Buy) $0.15 M 232842 Disposed 2026-08-19 Common Stock (232842) Direct

Footnotes

F1: The Reporting Person incorrectly listed the number of shares acquired via option exercise and is filing this Form 4 to correct the amount acquired.

F2: The Reporting Person incorrectly listed the number of shares exercised under the employee stock option and is filing this Form 4 to correct the amount acquired.

F3: One-fourth of the shares subject to the option vest on December 1, 2016 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F4: One-forty-eighth of the shares subject to the option vest on November 24, 2016 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.